4//SEC Filing
STANGER KENT W 4
Accession 0000856982-19-000037
CIK 0000856982other
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 9:00 PM ET
Size
18.2 KB
Accession
0000856982-19-000037
Insider Transaction Report
Form 4
STANGER KENT W
DirectorChief Financial Officer
Transactions
- Sale
Common Stock, No Par Value
2019-03-26$60.54/sh−1,216$73,618→ 431,099 total - Sale
Common Stock, No Par Value
2019-03-27$60.54/sh−901$54,548→ 430,198 total - Sale
Common Stock, No Par Value
2019-03-28$60.19/sh−2,883$173,517→ 427,315 total
Holdings
- 42,278(indirect: By 401(k))
Common Stock, No Par Value
- 9,375
Non-qualified stock options (right to buy)
Exercise: $19.72From: 2017-05-02Exp: 2023-05-02→ Common Stock (9,375 underlying) - 2,000
Non-qualified stock options (right to buy)
Exercise: $12.06From: 2015-10-04Exp: 2021-10-04→ Common Stock (2,000 underlying) - 25,000
Non-qualified stock options (right to buy)
Exercise: $18.80From: 2017-05-26Exp: 2023-05-26→ Common Stock (25,000 underlying) - 4,271
Common Stock, No Par Value
- 29,524(indirect: Family Limited Liability Company)
Common Stock, No Par Value
- 25,000
Non-qualified stock options (right to buy)
Exercise: $34.40From: 2018-05-24Exp: 2024-05-24→ Common Stock (25,000 underlying) - 25,000
Non-qualified stock options (right to buy)
Exercise: $50.50From: 2019-06-07Exp: 2025-06-07→ Common Stock (25,000 underlying)
Footnotes (11)
- [F1]Shares acquired under the Company's employee stock purchase plan.
- [F10]Becomes exercisable in equal annual installments of 20% commencing on 05/24/2018.
- [F11]Becomes exercisable in equal annual installments of 20% commencing on 06/07/2019.
- [F2]This report shall not be deemed an admission that the reporting person is the beneficial owner of the securities held by K.W.S. Properties LC.
- [F3]Represents plan holdings as of 03/28/2019.
- [F4]The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.50 to $60.58, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F5]The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.51 to $60.59, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F6]The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.33, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F7]Becomes exercisable in equal annual installments of 20% commencing on 10/04/2015.
- [F8]Becomes exercisable in equal annual installments of 20% commencing on 05/02/2017.
- [F9]Becomes exercisable in equal annual installments of 20% commencing on 05/26/2017.
Documents
Issuer
MERIT MEDICAL SYSTEMS INC
CIK 0000856982
Entity typeother
Related Parties
1- filerCIK 0000901531
Filing Metadata
- Form type
- 4
- Filed
- Mar 27, 8:00 PM ET
- Accepted
- Mar 28, 9:00 PM ET
- Size
- 18.2 KB